Ministers may find it hard to defend AstraZeneca vaccine plant blow given economic climate of contagious scepticism
In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow ...
Failed AstraZeneca deal is no way to sell Labour’s pro-growth ambitions
On supercomputers and life sciences, listening to Treasury naysayers risks letting work and political capital slip away ...
AstraZeneca investment deal ‘didn’t add up for UK taxpayer’, says minister
Science minister Sir Chris Bryant said the Government feels regretful about the plan being ditched and ‘would prefer to have got this over ...
FiercePharma7d
Merck vaccine, Daiichi ADC win approval recommendations in busy week at EU's drug regulator
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
devdiscourse6d
Global Health Front: Innovations, Challenges, and Market Shifts
This summary highlights significant health news, covering topics such as HIV treatment during U.S. aid pauses, Pfizer's diversity program legal settlement, AstraZeneca's halted UK investment, data ...
European Pharma Companies to Report 4Q Results With U.S Policy Uncertainty in Focus -- Sector Preview
Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...
Biotech Stocks Facing FDA Decision In February 2025
February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...